ARCHIVES

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

This article is from The Cancer Letter archive.

Vol. 05 No. 02 | January 12, 1979

Download PDF Visit The Full Archive

Related Articles

Kimes Calls Headline On DRG ‘Exaggerated Negativity’ In Letter

April 5, 1991

In Brief: Univ. Of Pittsburgh Creates Genetics Institute; Elion Inducted Into Inventors Hall of Fame

April 5, 1991

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

September 3, 1976

Obituary: Emmanuel Farber, Experimental Pathologist, Dies at Age 95

August 8, 2014

NCAB Discussion Of Working Group Report

February 28, 2003

Senate approves NIH funding bill. NCI awards $25 million to eight institutions for patient navigator programs; $35 million awarded for nanotechnology partnerships.

October 28, 2005